Sigma Planning Corp Sorrento Therapeutics, Inc. Call Options Transaction History

Sigma Planning Corp

  • $3.22 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

Apr 20, 2022
SELL
$2.0 - $4.9 $27,000 - $66,150
-13,500 Closed
0 $0
Q4 2021

Feb 02, 2022
SELL
$4.65 - $7.23 $64,635 - $100,497
-13,900 Reduced 50.73%
13,500 $63,000
Q3 2021

Oct 28, 2021
BUY
$7.41 - $10.99 $106,704 - $158,256
14,400 Added 110.77%
27,400 $209,000
Q2 2021

Aug 13, 2021
BUY
$6.35 - $10.0 $82,550 - $130,000
13,000 New
13,000 $126,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Sigma Planning Corp Portfolio

Follow Sigma Planning Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email